Abel Torres-Espin is assistant professor at the School of Public Health Sciences at the University of Waterloo in Canada; adjunct professor at the University of Alberta and assistant adjunct professor at the Brain and Spinal Injury Center in the Weill Institute of Neurosciences at University of California, San Francisco.
Abel Torres-Espin
Assistant adjunct professor
Brain and Spinal Injury Center (BASIC) University of California, San Francisco
From this contributor
By
Adam Ferguson, Hannah Radabaugh, Abel Torres-Espin
4 March 2024
7 min read
Pooling data points to new potential treatment for spinal cord injury
By gathering raw data from multiple labs, we identified an overlooked predictor of recovery after spinal cord injury. Many more insights remain trapped in scattered data.
Explore more from The Transmitter
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
By
Shaena Montanari
21 November 2024 | 2 min read
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
By
Claudia López Lloreda
20 November 2024 | 6 min read
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
By
Holly Barker
19 November 2024 | 2 min watch